Peter MacCallum Cancer Institute;Garvan Institute of Medical Research
发明人:
Swarbrick, Alex,Nikolic, Iva,Simpson, Kaylene
申请号：
AU2017276806
公开号：
AU2017276806A1
申请日:
2017.06.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
This disclosure relates to RNA interference (RNAi) reagents for treatment of neuroblastoma, compositions comprising same, and use thereof to treat individuals suffering from neuroblastoma as a monotherapy or in combination with a chemotherapeutic agent. In particular, the present disclosure relates to microRNAs (miRNAs) which affect viability of neuroblastoma cells.
